Natus Medical (NTUS) Business Metric Overview - Stocknear

Natus Medical

NASDAQ: NTUS · Real-Time Price · USD
32.96
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Natus Medical Revenue Breakdown

Period Ending Mar 31, 2022 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Jun 30, 2017 Mar 31, 2017 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Sep 30, 2013 Jun 30, 2013
Neurology Products Revenue 51.39M 70.05M 70.45M 69.06M 58.74M 43.51M 65.32M 72.19M 71.6M 62.39M 69.79M 70.41M 65.95M 59.29M 56.27M 56.75M 61.22M 56.67M 59.4M 58.63M 56.29M 58.69M 55.77M 56.49M 55.35M 52.78M
Neurology Products Revenue Growth -26.64% -0.58% +2.03% +17.57% +35.00% -33.39% -9.52% +0.83% +14.76% -10.60% -0.88% +6.76% +11.24% +5.36% -0.85% -7.30% +8.03% -4.60% +1.33% +4.16% -4.09% +5.23% -1.26% +2.05% +4.88% n/a
Newborn Care Products Revenue 19.39M 24.47M 26.35M 25.94M 25.71M 26.92M 24.23M 27M 26.56M 26.88M 31.21M 29.09M 30.89M 34.14M 40.63M 34.15M 34.74M 30.66M 35.18M 33.31M 33.11M 31.19M 30.55M 29.14M 30.04M 29.47M
Newborn Care Products Revenue Growth -20.76% -7.11% +1.57% +0.89% -4.48% +11.08% -10.27% +1.66% -1.18% -13.88% +7.30% -5.84% -9.51% -15.98% +18.97% -1.68% +13.31% -12.85% +5.61% +0.61% +6.16% +2.08% +4.85% -3.00% +1.92% n/a
Other Products Revenue 11.34M 19.36M 19.18M 19.93M 18.36M 14.36M 19.83M 24.27M 27.38M 25.49M 29.64M 31.16M 31.77M 28.8M 27.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Products Revenue Growth -41.41% +0.93% -3.79% +8.59% +27.88% -27.61% -18.28% -11.37% +7.42% -14.00% -4.88% -1.93% +10.31% +3.76% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Otometrics Revenue 37.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Otometrics Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Jun 30, 2018 Mar 31, 2018 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012
Foreign Countries Revenue 49.82M 75.36M 41.76M 45.24M 47.16M 69.31M 39.25M 33.6M 41.05M 79.34M 49.91M 52.01M 48.69M 55.19M 59.94M 55.15M 59.95M 63.76M 28.39M 28.43M 30.43M 64.42M 32.03M 31.43M 34.83M 36.01M 33.18M 33.86M 37.28M 33.98M 34.31M 37.48M 39.98M 33.33M 26.89M
Foreign Countries Revenue Growth -33.88% +80.43% -7.69% -4.06% -31.97% +76.60% +16.80% -18.13% -48.27% +58.98% -4.03% +6.81% -11.77% -7.93% +8.68% -8.00% -5.98% +124.58% -0.14% -6.57% -52.77% +101.13% +1.90% -9.76% -3.28% +8.55% -2.01% -9.18% +9.71% -0.98% -8.45% -6.24% +19.95% +23.95% n/a
United States Revenue 69.97M n/a 72.11M 70.74M 67.77M n/a 63.55M 51.17M 68.34M n/a 73.55M 73.53M 66.07M 75.47M 68.67M 67.08M 64.71M n/a 62.52M 67.53M 56.9M n/a 62.55M 60.51M 54.56M 58M 56.7M 52.47M 48.35M n/a 47.94M n/a n/a n/a n/a
United States Revenue Growth n/a n/a +1.95% +4.37% n/a n/a +24.19% -25.11% n/a n/a +0.03% +11.30% -12.46% +9.90% +2.38% +3.65% n/a n/a -7.42% +18.68% n/a n/a +3.38% +10.89% -5.92% +2.29% +8.07% +8.53% n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 42.36M 41.73M 41.11M 42.1M 43.83M 40.07M 38.42M 33.99M 43.91M 47.84M 45.96M 44.93M 50.03M 45.94M 49M 57.12M 53.32M 47.98M 49.87M 54.51M 48.23M 36.91M 32.57M 33.16M 33.08M 35.45M 32.53M 33.76M 32.29M
Selling, General, and Administrative Revenue Growth +1.50% +1.50% -2.34% -3.94% +9.36% +4.31% +13.03% -22.60% -8.20% +4.08% +2.30% -10.21% +8.91% -6.25% -14.22% +7.13% +11.12% -3.78% -8.52% +13.02% +30.68% +13.33% -1.79% +0.25% -6.70% +9.00% -3.67% +4.55% n/a
Research and Development Revenue 13.22M 13.75M 14.27M 14.25M 14.04M 14.72M 14.67M 14.34M 17.57M 18.79M 14.11M 12.77M 13.06M 15.3M 15.13M 15.62M 15.44M 13.72M 11.63M 13.71M 12.75M 10.85M 7.69M 7.11M 7.8M 8.57M 7.7M 7.31M 6.86M
Research and Development Revenue Growth -3.83% -3.62% +0.13% +1.49% -4.63% +0.35% +2.33% -18.40% -6.51% +33.14% +10.53% -2.21% -14.63% +1.12% -3.13% +1.12% +12.53% +17.98% -15.18% +7.53% +17.57% +41.07% +8.22% -8.93% -8.93% +11.26% +5.35% +6.59% n/a
Sales and Marketing Revenue 29.55M 29.3M 28.26M 29.49M 28.97M 27.71M 26.04M 22.8M 30.73M 32.3M 30.85M 32.24M 33.73M 34.21M 33.2M 33.4M 35.87M 31.06M 32.54M 30.35M 32.22M 23.26M 19.75M 21.24M 20.6M 22.33M 22.5M 22.11M 20.74M
Sales and Marketing Revenue Growth +0.87% +3.66% -4.16% +1.78% +4.53% +6.45% +14.18% -25.80% -4.85% +4.69% -4.31% -4.43% -1.39% +3.03% -0.60% -6.89% +15.49% -4.54% +7.19% -5.78% +38.52% +17.78% -7.02% +3.11% -7.77% -0.73% +1.75% +6.59% n/a